Literature DB >> 15840596

Positive clinical and biochemical responses to anakinra in a 3-yr-old patient with cryopyrin-associated periodic syndrome (CAPS).

E Ramos, J I Aróstegui, S Campuzano, J Rius, C Bousoño, J Yagüe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15840596     DOI： 10.1093/rheumatology/keh652

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  10 in total

1.  Anakinra in mutation-negative CINCA syndrome.

Authors:  José Luis Callejas; Javier Oliver; Javier Martín; Norberto Ortego
Journal:  Clin Rheumatol       Date:  2006-01-27       Impact factor: 2.980

Review 2.  The PYRIN domain in signal transduction.

Authors:  Christian Stehlik
Journal:  Curr Protein Pept Sci       Date:  2007-06       Impact factor: 3.272

Review 3.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

4.  Extreme efficiency of anti-interleukin 1 agent (anakinra) in a Japanese case of CINCA syndrome.

Authors:  Yasuyo Kashiwagi; Hisashi Kawashima; Shigeo Nishimata; Ryuhei Nagao; Kiyoko Watanabe; Kouji Takekuma; Akinori Hoshika
Journal:  Clin Rheumatol       Date:  2007-09-22       Impact factor: 2.980

Review 5.  Autoinflammation: From monogenic syndromes to common skin diseases.

Authors:  Tien V Nguyen; Edward W Cowen; Kieron S Leslie
Journal:  J Am Acad Dermatol       Date:  2013-02-28       Impact factor: 11.527

6.  Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response.

Authors:  Justin R Yu; Kieron S Leslie
Journal:  Curr Allergy Asthma Rep       Date:  2011-02       Impact factor: 4.806

7.  Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS).

Authors:  Jasmin B Kuemmerle-Deschner; Eduardo Ramos; Norbert Blank; Joachim Roesler; Sandra D Felix; Thomas Jung; Kirstin Stricker; Abhijit Chakraborty; Stacey Tannenbaum; Andrew M Wright; Christiane Rordorf
Journal:  Arthritis Res Ther       Date:  2011-02-28       Impact factor: 5.156

Review 8.  Biological treatments: new weapons in the management of monogenic autoinflammatory disorders.

Authors:  Antonio Vitale; Donato Rigante; Orso Maria Lucherini; Francesco Caso; Isabella Muscari; Flora Magnotti; Maria Giuseppina Brizi; Susanna Guerrini; Maria Patti; Leonardo Punzi; Mauro Galeazzi; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2013-07-21       Impact factor: 4.711

Review 9.  The inflammasomes, immune guardians at defence barriers.

Authors:  Pablo Palazon-Riquelme; Gloria Lopez-Castejon
Journal:  Immunology       Date:  2018-09-06       Impact factor: 7.397

10.  Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade.

Authors:  Florence Allantaz; Damien Chaussabel; Dorothee Stichweh; Lynda Bennett; Windy Allman; Asuncion Mejias; Monica Ardura; Wendy Chung; Elisabeth Smith; Carol Wise; Karolina Palucka; Octavio Ramilo; Marilynn Punaro; Jacques Banchereau; Virginia Pascual
Journal:  J Exp Med       Date:  2007-08-27       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.